Scientific Publications

Search by Keyword(s)
Found 7 results

Filters: Author is Kutok, JL  [Clear All Filters]

Search Results

  • Showing 1-7 of 7 Results
2012
Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma.Monti, S., Chapuy B., Takeyama K., Rodig SJ, Hao Y., Yeda KT, Inguilizian H., Mermel C., Currie T., Dogan A., Kutok JL, Beroukhim R., Neuberg D., Habermann TM, Getz G., Kung AL, Golub T. R., and Shipp M. A. Cancer cell, 2012/09/11, Volume 22, Issue 3, p.359-72, (2012) Read More / View Supplemental Materials
Abstract
2011
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.Green, MR, Monti S., Dalla-Favera R., Pasqualucci L., Walsh NC, Schmidt-Supprian M., Kutok JL, Rodig SJ, Neuberg DS, Rajewsky K., Golub T. R., Alt F. W., Shipp M. A., and Manis J. P. Proceedings of the National Academy of Sciences of the United States of America, 2011/02/15, Volume 108, Issue 7, p.2873-8, (2011) Read More / View Supplemental Materials
Abstract
2010
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.Green, MR, Monti S., Rodig SJ, Juszczynski P., Currie T., O'Donnell E., Chapuy B., Takeyama K., Neuberg D., Golub T. R., Kutok JL, and Shipp M. A. Blood, 2010/10/28, Volume 116, Issue 17, p.3268-77, (2010) Read More / View Supplemental Materials
Abstract
2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility.Shepard, JL, Amatruda JF, Stern HM, Subramanian A., Finkelstein D., Ziai J., Finley KR, Pfaff KL, Hersey C., Zhou Y., Barut B., Freedman M., Lee C., Spitsbergen J., Neuberg D., Weber G., Golub T. R., Glickman JN, Kutok JL, Aster J. C., et al. Proceedings of the National Academy of Sciences of the United States of America, 2005/09/13, Volume 102, Issue 37, p.13194-9, (2005) Read More / View Supplemental Materials
Abstract
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.Feuerhake, F., Kutok JL, Monti S., Chen W., LaCasce AS, Cattoretti G., Kurtin P., Pinkus GS, de Leval L., Harris NL, Savage KJ, Neuberg D., Habermann TM, Dalla-Favera R., Golub T. R., Aster J. C., and Shipp M. A. Blood, 2005/08/15, Volume 106, Issue 4, p.1392-9, (2005) Read More / View Supplemental Materials
Abstract
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.Monti, S., Savage KJ, Kutok JL, Feuerhake F., Kurtin P., Mihm M., Wu B., Pasqualucci L., Neuberg D., Aguiar RC, Dal Cin P., Ladd C., Pinkus GS, Salles G., Harris NL, Dalla-Favera R., Habermann TM, Aster J. C., Golub T. R., and Shipp M. A. Blood, 2005/03/01, Volume 105, Issue 5, p.1851-61, (2005) Read More / View Supplemental Materials
Abstract
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.Wang, J., Iwasaki H., Krivtsov A., Febbo PG, Thorner AR, Ernst P., Anastasiadou E., Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub T. R., Armstrong SA, Akashi K., and Korsmeyer SJ The EMBO journal, 2005/01/26, Volume 24, Issue 2, p.368-81, (2005) Read More / View Supplemental Materials
Abstract
  • Showing 1-7 of 7 Results